|
1
|
Zhang Z and Lin CC: Taking advantage of
neural development to treat glioblastoma. Eur J Neurosci.
40:2859–2866. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van den Bent MJ, Hegi ME and Stupp R:
Recent developments in the use of chemotherapy in brain tumours.
Eur J Cancer. 42:582–588. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Giese A, Bjerkvig R, Berens ME and
Westphal M: Cost of migration: Invasion of malignant gliomas and
implications for treatment. J Clin Oncol. 21:1624–1636. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou YH, Tan F, Hess KR and Yung WK: The
expression of PAX6, PTEN, vascular endothelial growth factor, and
epidermal growth factor receptor in gliomas: Relationship to tumor
grade and survival. Clin Cancer Res. 9:3369–3375. 2003.PubMed/NCBI
|
|
6
|
Zhou YH, Wu X, Tan F, Shi YX, Glass T, Liu
TJ, Wathen K, Hess KR, Gumin J, Lang F and Yung WK: PAX6 suppresses
growth of human glioblastoma cells. J Neurooncol. 71:223–229. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mayes DA, Hu Y, Teng Y, Siegel E, Wu X,
Panda K, Tan F, Yung WK and Zhou YH: PAX6 suppresses the
invasiveness of glioblastoma cells and the expression of the matrix
metalloproteinase-2 gene. Cancer Res. 66:9809–9817. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang BS, Luo QZ, Han Y, Li XB, Cao LJ and
Wu LX: microRNA-223 promotes the growth and invasion of
glioblastoma cells by targeting tumor suppressor PAX6. Oncol Rep.
30:2263–2269. 2013.PubMed/NCBI
|
|
9
|
Ma R, Jiang T and Kang X: Circulating
microRNAs in cancer: Origin, function and application. J Exp Clin
Cancer Res. 31:382012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jones KB, Salah Z, Del Mare S, Galasso M,
Gaudio E, Nuovo GJ, Lovat F, LeBlanc K, Palatini J, Randall RL, et
al: miRNA signatures associate with pathogenesis and progression of
osteosarcoma. Cancer Res. 72:1865–1877. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hermansen SK and Kristensen BW: MicroRNA
biomarkers in glioblastoma. J Neurooncol. 114:13–23. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shi L, Chen J, Yang J, Pan T, Zhang S and
Wang Z: MiR-21 protected human glioblastoma U87MG cells from
chemotherapeutic drug temozolomide induced apoptosis by decreasing
Bax/Bcl-2 ratio and caspase-3 activity. Brain Res. 1352:255–264.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang S, Wan Y, Pan T, Gu X, Qian C, Sun
G, Sun L, Xiang Y, Wang Z and Shi L: MicroRNA-21 inhibitor
sensitizes human glioblastoma U251 stem cells to chemotherapeutic
drug temozolomide. J Mol Neurosci. 47:346–356. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang J, Sai K, Chen FR and Chen ZP:
miR-181b modulates glioma cell sensitivity to temozolomide by
targeting MEK1. Cancer Chemother Pharmacol. 72:147–158. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mesti T, Savarin P, Triba MN, Le Moyec L,
Ocvirk J, Banissi C and Carpentier AF: Metabolic impact of
anti-angiogenic agents on U87 glioma cells. PLoS One. 9:e991982014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Olivares S, Green RM and Henkel AS:
Endoplasmic reticulum stress activates the hepatic activator
protein 1 complex via mitogen activated protein kinase-dependent
signaling pathways. PLoS One. 9:e1038282014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ding X, Zhang Z, Li S and Wang A:
Combretastatin A4 phosphate induces programmed cell death in
vascular endothelial cells. Oncol Res. 19:303–309. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fazi F, Rosa A, Fatica A, Gelmetti V, De
Marchis ML, Nervi C and Bozzoni I: A minicircuitry comprised of
microRNA-223 and transcription factors NFI-A and C/EBPalpha
regulates human granulopoiesis. Cell. 123:819–831. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stamatopoulos B, Meuleman N, Haibe-Kains
B, Saussoy P, Van Den Neste E, Michaux L, Heimann P, Martiat P,
Bron D and Lagneaux L: microRNA-29c and microRNA-223
down-regulation has in vivo significance in chronic lymphocytic
leukemia and improves disease risk stratification. Blood.
113:5237–5245. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wong QW, Lung RW, Law PT, Lai PB, Chan KY,
To KF and Wong N: MicroRNA-223 is commonly repressed in
hepatocellular carcinoma and potentiates expression of Stathmin1.
Gastroenterology. 135:257–269. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nian W, Ao X, Wu Y, Huang Y, Shao J, Chen
Z, Chen F and Wang D: miR-223 functions as a potent tumor
suppressor of the Lewis lung carcinoma cell line by targeting
insulin-like growth factor-1 receptor and cyclin-dependent kinase
2. Oncol Lett. 6:359–366. 2013.PubMed/NCBI
|
|
23
|
Gottardo F, Liu CG, Ferracin M, Calin GA,
Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, et
al: Micro-RNA profiling in kidney and bladder cancers. Urol Oncol.
25:387–392. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kurashige J, Watanabe M, Iwatsuki M,
Kinoshita K, Saito S, Hiyoshi Y, Kamohara H, Baba Y, Mimori K and
Baba H: Overexpression of microRNA-223 regulates the ubiquitin
ligase FBXW7 in oesophageal squamous cell carcinoma. Br J Cancer.
106:182–188. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li X, Zhang Y, Zhang H, Liu X, Gong T, Li
M, Sun L, Ji G, Shi Y, Han Z, et al: miRNA-223 promotes gastric
cancer invasion and metastasis by targeting tumor suppressor
EPB41L3. Mol Cancer Res. 9:824–833. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu YH, Zhang L, Wu DS, Zhang Z, Huang FF,
Zhang J, Chen XP, Liang DS, Zeng H and Chen FP: MiR-223 regulates
human embryonic stem cell differentiation by targeting the
IGF-1R/Akt signaling pathway. PLoS One. 8:e787692013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bhattacharya S, Das A, Mallya K and Ahmad
I: Maintenance of retinal stem cells by Abcg2 is regulated by notch
signaling. J Cell Sci. 120:2652–2662. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma B, Lei X, Guan Y, Mou LS, Yuan YF, Yue
H, Lu Y, Xu GT and Qian J: Maintenance of retinal cancer stem
cell-like properties through long-term serum-free culture from
human retinoblastoma. Oncol Rep. 26:135–143. 2011.PubMed/NCBI
|
